Agostino Nozzolillo

COVID-19 Severity in Multiple Sclerosis

Maria Pia Sormani, Irene Schiavetti, Luca Carmisciano et al. · Neurology Neuroimmunology & Neuroinflammation · 2021 · 74 citations · Full text

Public Health, Internal Medicine, Clinical Epidemiology +16

COVID‐19 pandemic and mental distress in multiple sclerosis: Implications for clinical management

Teresa Costabile, Antonio Carotenuto, Giovanna Borriello et al. · European Journal of Neurology · 2020 · 64 citations · Full text

Nursing, Neurology, Psychology +16

Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience

Chiara Zecca, Francesca Bovis, Giovanni Novi et al. · Multiple Sclerosis Journal · 2019 · 58 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience

Sara Guerrieri, Serena Marita Lazzarin, Chiara Zanetta et al. · Journal of Neurology · 2021 · 55 citations · Full text

Life Sciences, Immunology, Neurology +15

Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)

Antonietta Coppola, Alessia Zarabla, Andrea Maialetti et al. · Frontiers in Neurology · 2020 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14